Proteomics of the rat myocardium during development of type 2 diabetes mellitus reveals progressive alterations in major metabolic pathways
AV Edhager, JA Povlsen, B Løfgren… - Journal of Proteome …, 2018 - ACS Publications
Congestive heart failure and poor clinical outcome after myocardial infarction are known
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
Proteomics of the Rat Myocardium during Development of Type 2 Diabetes Mellitus Reveals Progressive Alterations in Major Metabolic Pathways.
AV Edhager, JA Povlsen, B Løfgren… - Journal of Proteome …, 2018 - europepmc.org
Congestive heart failure and poor clinical outcome after myocardial infarction are known
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
Proteomics of the Rat Myocardium during Development of Type 2 Diabetes Mellitus Reveals Progressive Alterations in Major Metabolic Pathways
AV Edhager, JA Povlsen, B Løfgren… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Congestive heart failure and poor clinical outcome after myocardial infarction are known
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
Proteomics of the rat myocardium during development of type 2 diabetes mellitus reveals progressive alterations in major metabolic pathways
AV Edhager, JA Povlsen, B Løfgren, HE Bøtker… - Journal of Proteome …, 2018 - pure.au.dk
Congestive heart failure and poor clinical outcome after myocardial infarction are known
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …
complications in patients with type-2 diabetes mellitus (T2DM). Protein alterations may be …